Stocks and Investing
Stocks and Investing
Mon, May 13, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Biegler Reiterated (TYRA) at Buy with Increased Target to $28 on, May 13th, 2024
Matthew Biegler of Oppenheimer, Reiterated "Tyra Biosciences, Inc." (TYRA) at Buy with Increased Target from $25 to $28 on, May 13th, 2024.
Matthew has made no other calls on TYRA in the last 4 months.
There are 2 other peers that have a rating on TYRA. Out of the 2 peers that are also analyzing TYRA, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Friday, May 10th, 2024
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $28 on, Friday, May 10th, 2024
Contributing Sources